Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Land & Improvements (2016 - 2024)

Historic Land & Improvements for Utah Medical Products (UTMD) over the last 14 years, with Q4 2024 value amounting to $1.6 million.

  • Utah Medical Products' Land & Improvements fell 207.57% to $1.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.6 million, marking a year-over-year decrease of 207.57%. This contributed to the annual value of $1.6 million for FY2024, which is 207.57% down from last year.
  • As of Q4 2024, Utah Medical Products' Land & Improvements stood at $1.6 million, which was down 207.57% from $1.6 million recorded in Q4 2023.
  • Utah Medical Products' Land & Improvements' 5-year high stood at $1.7 million during Q4 2020, with a 5-year trough of $1.6 million in Q4 2022.
  • Its 5-year average for Land & Improvements is $1.6 million, with a median of $1.6 million in 2023.
  • In the last 5 years, Utah Medical Products' Land & Improvements surged by 323.16% in 2020 and then plummeted by 573.96% in 2022.
  • Quarter analysis of 5 years shows Utah Medical Products' Land & Improvements stood at $1.7 million in 2020, then decreased by 2.03% to $1.7 million in 2021, then fell by 5.74% to $1.6 million in 2022, then grew by 2.82% to $1.6 million in 2023, then fell by 2.08% to $1.6 million in 2024.
  • Its Land & Improvements stands at $1.6 million for Q4 2024, versus $1.6 million for Q4 2023 and $1.6 million for Q4 2022.